Danielle Bitterman: Consensus guidelines for reporting LLM research in biomedicine
Danielle Bitterman, Assistant Professor at Harvard Medical School, posted on X about recent paper by her as co-author, titled “The TRIPOD-LLM reporting guideline for studies using large language models” published on Nature Medicine.
Authors: Jack Gallifant, Majid Afshar, Saleem Ameen, Yindalon Aphinyanaphongs, Shan Chen, Giovanni Cacciamani, Dina Demner-Fushman, Dmitriy Dligach, Roxana Daneshjou, Chrystinne Fernandes, Lasse Hyldig Hansen, Adam Landman, Lisa Lehmann, Liam G. McCoy, Timothy Miller, Amy Moreno, Nikolaj Munch, David Restrepo, Guergana Savova, Renato Umeton, Judy Wawira Gichoya, Gary S. Collins, Karel G. M. Moons, Leo A. Celi, Danielle S. Bitterman
“TRIPOD-LLM is out! Check out our consensus guidelines for reporting LLM research in biomedicine. TRIPOD-LLM is intended to be a living guideline to keep up with the rapid advances in LLMs/Gen AI. Kudos to lead author Jack Gallifant.”
Dr. Danielle Bitterman is an Assistant Professor at Harvard Medical School and an Attending Physician at Dana-Farber Cancer Institute. She is also an Associate Editor for Radiation Oncology at HemOnc.org. As a physician-scientist, her research focuses on leveraging AI advancements to improve cancer care.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023